Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Commodore Capital LP's stake in Karyopharm Therapeutics Inc. fell below 5% (Schedule 13G/A)
Filed Aug 14, 2026
Commodore Capital LP's stake in Karyopharm Therapeutics Inc. fell below 5%, 0 shares, as a passive investor. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 0% | 0 |
| Commodore Capital Master LP | 0% | 0 |
| Robert Egen Atkinson | 0% | 0 |
| Michael Kramarz | 0% | 0 |
Source
Related
- Karyopharm Therapeutics Inc.
- Commodore Capital LP
- Karyopharm Therapeutics Inc. shareholders
- Schedule 13G · Commodore Capital LP · Apr 2, 2026
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026